Therefore, the aim of the present study is to investigate whether a selective VAP-1/SSAO inhibitor (PXS-4728A) can reduce atherosclerosis in cholesterol-fed New Zealand White rabbits and to explore the potential molecular mechanisms. Here, AOC3 is linked to atherosclerosis.